Evaluation of barriers and facilitators to ongoing PrEP use: Clinical Trials

1 trial of Evaluation of barriers and facilitators to ongoing PrEP use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Evaluation of barriers and facilitators to ongoing PrEP use: new trials by email Literature Review of Evaluation of barriers and facilitators to ongoing PrEP use trials Research Report on Evaluation of barriers and facilitators to ongoing PrEP use

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi
PrEP eligibility assessment, Rapid HIV antibody testing prior to provision and/or refill of PrEP, PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines - HIV Infection, Sexually Transmitted Infections
Not applicableCompletedHIV Prevention Trials Network1992024-04-022025-12-12

Conditions studied

HIV Infections (1)  ·  Heterosexuality (1)  ·  Sexually Transmitted Diseases (1)

Sponsors

HIV Prevention Trials Network (1)

Countries

Malawi (1)

Top investigators

Mitch Matoga, MBBS, MSc (1)  ·  Sarah Rutstein, MD, PhD (1)

Results publications

PMID 40531570

NIH funding

UM1AI068619-17 (1)